Breaking News, Promotions & Moves

WuXi Vaccines Names Jian Dong as CEO

The vaccine CDMO is a joint venture between WuXi Biologics and Shanghai-based Hile Bio-Technology.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi Vaccines, a global vaccine contract development and manufacturing organization (CDMO), has appointed Jian Dong as chief executive officer. WuXi Vaccines is a joint venture established between WuXi Biologics and Shanghai-based Hile Bio-Technology.   “We are delighted to announce Jian’s new appointment. He is a highly regarded leader with over 30 years of bio-pharmaceutical experience, including vaccine production, process development, as well as the design, construction, qualific...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters